Literature DB >> 9418144

Bone grafting to the maxillary sinuses, nasal floor and anterior maxilla in the atrophic edentulous maxilla. A two-stage technique.

S Lundgren1, E Nyström, H Nilson, J Gunne, O Lindhagen.   

Abstract

This study presents the results from 20 consecutive patients treated with an autogenous bone graft from the iliac crest. In ten patients the graft was placed in the maxillary sinuses and the floor of the nose (inlay group). Ten patients, in addition to the inlay graft, had a corticocancellous bone block secured with mini-screws to the anterior maxillary ridge (inlay/onlay group). Endosteal implants (Brånemark) were placed six months after surgery. A total of 136 implants were placed, of which eight failed to integrate during the six-month healing period. A further 15 implants were lost during the follow-up period. For the inlay group the average follow-up period was 22 months and for the inlay/onlay group 19 months. Donor site morbidity was significantly less when iliac bone was harvested with a trephine (inlay group) than in patients treated with our routine procedure for bone harvesting (inlay/onlay group). Surgical technique, donor site morbidity, implant survival and patient acceptance are presented.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9418144     DOI: 10.1016/s0901-5027(97)80007-0

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  9 in total

1.  8-10 year follow-up survival of dental implants in maxillae with or without autogenous bone graft reconstruction.

Authors:  Paulo H de Moraes; Sergio Olate; Andrezza Lauria; Luciana Asprino; Márcio de Moraes; José Ricardo de Albergaria-Barbosa
Journal:  Int J Clin Exp Med       Date:  2015-10-15

2.  Full rehabilitation with nobel clinician(®) and procera implant bridge(®): case report.

Authors:  D Spinelli; L Ottria; G DE Vico; R Bollero; A Barlattani; P Bollero
Journal:  Oral Implantol (Rome)       Date:  2013-10-15

3.  Immediate loading of four implants (BTLock(®)) in the maxilla and provisional restoration with guide-surgery (SimPlant, Materialise(®)): case report.

Authors:  D Spinelli; G DE Vico; R Schiavetti; M Bonino; A Pozzi; P Bollero; A Barlattani
Journal:  Oral Implantol (Rome)       Date:  2010-11-29

4.  [Combined sinus lift procedure and lateral augmentation. A treatment concept for the surgical and prosthodontic rehabilitation of the extremely atrophic maxilla].

Authors:  D Weingart; R Bublitz; G Petrin; J Kälber; S Ingimarsson
Journal:  Mund Kiefer Gesichtschir       Date:  2005-09

5.  Maxillary sinus floor augmentation on humans: Packing simulations and 8 months histomorphometric comparative study of anorganic bone matrix and β-tricalcium phosphate particles as grafting materials.

Authors:  A Martinez; J Franco; E Saiz; F Guitian
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2010-06-15       Impact factor: 7.328

6.  Transcrestal guided sinus lift without grafting materials: a 36 months clinical prospective study.

Authors:  D Spinelli; G DE Vico; R Condò; L Ottria; C Arcuri
Journal:  Oral Implantol (Rome)       Date:  2016-07-25

7.  Nasal floor augmentation for the reconstruction of the atrophic maxilla: a case series.

Authors:  Moustafa El-Ghareeb; Joan Pi-Anfruns; Mohammed Khosousi; Tara Aghaloo; Peter Moy
Journal:  J Oral Maxillofac Surg       Date:  2011-12-16       Impact factor: 1.895

8.  Osseointegration aspects of placed implant in bone reconstruction with newly developed block-type interconnected porous calcium hydroxyapatite.

Authors:  Kazuya Doi; Takayasu Kubo; Yusuke Makihara; Hiroshi Oue; Koji Morita; Yoshifumi Oki; Shiho Kajihara; Kazuhiro Tsuga
Journal:  J Appl Oral Sci       Date:  2016 Jul-Aug       Impact factor: 2.698

9.  Vestibular bone thickness of the mandible in relation to the mandibular canal-a retrospective CBCT-based study.

Authors:  Silvio Valdec; Jan M Borm; Stephanie Casparis; Georg Damerau; Michael Locher; Bernd Stadlinger
Journal:  Int J Implant Dent       Date:  2019-11-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.